高分辨率低剂量胸部CT在健康体检中的应用价值

doi:10.20223/j.cnki.1000-8535.2024.11.017

摘要/Abstract

摘要： 目的探讨高分辨率低剂量CT（HRLDCT）在无症状健康体检者筛查肺部疾病和肺外病变的应用价值。方法回顾性分析于2011年1月—2021年12月在广州市第一人民医院行胸部HRLDCT检查的1 940例无症状健康体检者的影像学资料,由两位研究者分别评估和记录所有受检者的每一个阳性CT病征征象,分析各个阳性CT征象在总受检人群中的检出情况、各个阳性CT征象在性别、年龄分层中的分布情况,以及肺外阳性CT征象检出情况。比较肺癌和肺良性结节在不同性别、不同年龄段分布中的检出情况。结果共有1 831例受检者存在阳性CT征象,总检出率为94.38%,共检出3 339个阳性CT征象。检出率最高的阳性CT征象是肺部良性结节（1 630例,84.02%）。在973例男性受检者中,检出肺癌22例（2.26%）,肺良性结节 815例（83.73%）;在967例女性受检者中,检出肺癌19例（1.96%）,肺良性结节815例（84.28%）,肺癌与肺良性结节在不同性别间的检出率比较差异无统计学意义（P=0.64,χ²=0.214）。肺部阳性CT征象的检出率随年龄的增长而升高,肺癌与肺良性结节最多见于51~60岁受检人群中,两者在51~60岁和61~70岁中的检出率比较差异有统计学意义（P=0.038,χ²=4.32）。此外,检出最多的肺外其他阳性CT征象为脂肪肝,共497例（25.62%）,其次是冠状动脉钙化173例（8.90%）。结论 HRLDCT在胸部的健康体检中可同时用于肺部疾病的筛查及发现肺外异常征象,具有较高的临床应用价值。

关键词: 高分辨率低剂量CT, 肺癌, 肺结节, 健康体检, 肺部疾病

Abstract: Objective To investigate the application value of high-resolution low-dose CT（HRLDCT）in screening for lung diseases and extra-pulmonary lesions in asymptomatic healthy individuals．Methods A retrospective analysis was performed on the images of 1 940 asymptomatic healthy individuals who underwent chest HRLDCT examination in our hospital from January 2011 to December 2021．Two investigators conducted independent evaluations and recordings of each positive CT sign in all individuals．An analysis of the detection rates of positive CT signs in the entire population,examining their distribution across various gender and age groups was involved in this study．The detection of positive CT signs outside the lung was also investigated．Additionally,the comparative analysis of lung cancer and benign pulmonary nodules detection across various genders and age cohorts were performed．Results A comprehensive count of 1831 individuals exhibited positive CT signs,resulting in an overall detection rate of 94．38%,with identifying a total of 3339 positive CT signs．The positive CT sign with the highest detection rate was benign pulmonary nodule（1 630 cases,84.02%）．In 973 male participants,22 cases of lung cancer were detected（2.26%）,and 815 cases of benign lung nodules were found（83.73%）．In 967 female participants,19 cases of lung cancer were detected（1.96%）,and 815 cases of benign lung nodules were identified（84.28%）．Statistical analysis revealed no significant difference in the detection rates of lung cancer and benign lung nodules between genders（P=0.64,χ²=0.214）．The prevalence of positive CT signs in the lungs demonstrates an upward trend with advancing age．Notably,individuals aged 51-60 exhibit a higher incidence of lung cancer and benign lung nodules．A statistically significant disparity in the detection rates of these conditions is observed between the 51-60 and 61-70 age cohorts（P=0.038,χ²=4.32）．In addition,the most frequently detected extrapulmonary positive CT findings were fatty liver,with a total of 497 cases（25.62%）,followed by coronary artery calcification with 173 cases（8.90%）．Conclusion sHRLDCT can be effectively employed in the screening of pulmonary conditions and identification of extra-pulmonary abnormalities during thoracic health assessments,demonstrating considerable clinical significance．

Key words: high-resolution low-dose computed tomography, lung cancer, pulmonary nodule, health examination, pulmonary diseases

李文菁, 言佳锋. 高分辨率低剂量胸部CT在健康体检中的应用价值[J]. 广州医药, 2024, 55(11): 1343-1349.

LI Wenjing, YAN Jiafeng. The application value of high-resolution low-dose chest CT in health screening[J]. Guangzhou Medical Journal, 2024, 55(11): 1343-1349.

参考文献

[1] 刘登平,张捷,宋雪燕,等.高分辨CT联合最大密度投影重建对肺结节检出效能的评价[J].国际医药卫生导报,2024,30(2):288-291.
[2] 张志成,黄运杰,李沐盛.胸部低剂量CT对健康体检者肺结节及肺癌的筛查价值分析[J].临床医学工程,2020,27(10):1285-1286.
[3] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[4] ZHENG R,ZHANG S,ZENG H,et al.Cancer incidence and mortality in China,2016[J].J Natl Cancer Cent,2022,2(1):1-9.
[5] 陈宏达,郑荣寿,王乐,等.2019年中国肿瘤流行病学研究进展[J].中华疾病控制杂志,2020,24(4):373-379.
[6] WALTERS S,MARINGE C,COLEMAN M P,et al.Lung cancer survival and stage at diagnosis in Australia,Canada,Denmark,Norway,Sweden and the UK:A population-based study,2004-2007[J].Thorax,2013,68(6):551-564.
[7] YU Z,NI P,YU H,et al.Effectiveness of a single low-dose computed tomography screening for lung cancer: A population-based perspective cohort study in China[J].Int J Cancer,2024,154(4):659-669.
[8] MARTÍNEZ PÉREZ E,de AGUIAR QUEVEDO K,ARRARÁS MARTÍNEZ M,et al.Lung cancer screening:Use of low-dose computed tomography[J].Arch Bronconeumol 2019,55(10):526-531.
[9] HENSCHKE C,HUBER R,JIANG L,et al.Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening from the IASLC early detection & screening committee[J].Thorac Oncol,2024,19(4):565-580.
[10] 谭培兰. 小剂量螺旋CT在胸部健康体检中的价值[J].医疗装备,2017,30(18):35-36.
[11] GENDARME S,GOUSSAULT H,ASSIÉ J B,et al.Impact on all-cause and cardiovascular mortality rates of coronary artery calcifications detected during organized,low-dose,computed-tomography screening for lung cancer:Systematic literature review and Meta-analysis[J].Cancers,2021,13(7):1553.
[12] 邓惠兰. 胸部透视漏诊和误诊病例分析[J].中国社区医师(医学专业),2010,12(25):31.
[13] 田佰柱. X线胸透、胸片在健康体检中筛查肺癌的调查研究[J].世界最新医学信息文摘,2018,18(24):186.
[14] 闫忠,王云俊,许海英,等.低剂量螺旋CT扫描在早期肺癌诊断中的应用价值[J].临床合理用药杂志,2014,7(13):122-123.
[15] 崔琳琳. 高分辨率CT在良恶性肺磨玻璃结节鉴别诊断中的应用价值[J].临床医学,2024,44(1):87-89.
[16] 李超,王道清,郭伟,等.CT征象在预测亚实性肺腺癌结节侵袭风险中的价值[J].广州医药,2023,54(8):46-51.
[17] 余辉山,秦立新,丁晨宇,等.250例新型冠状病毒肺炎高分辨率CT特征分析[J].结核病与肺部健康杂志,2020,9(1):19-24.
[18] National Lung Screening Trial Research Team,ABERLE D R,ADAMS A M,et al.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409.
[19] BECKER N,MOTSCH E,TROTTER A,et al.Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial[J].Int J Cancer,2020,146(6):1503-1513.
[20] de KONING H J,van der AALST C M,de JONG P A,et al.Reduced lung-cancer mortality with volume CT screening in a randomized trial[J].N Engl J Med,2020,382(6):503-513.
[21] PASTORINO U,SILVA M,SESTINI S,et al.Prolonged lung cancer screening reduced 10-year mortality in the MILD trial:New confirmation of lung cancer screening efficacy[J].Ann Oncol,2019,30(10):1672.
[22] CHANG G C,CHIU C H,YU C J,et al.Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan:A prospective cohort study[J].Lancet Respir Med,2024,12(2):141-152.[23] YANG W,QIAN F,TENG J,et al.Community-based lung cancer screening with low-dose CT in China:Results of the baseline screening[J].Lung Cancer,2018(117):20-26.
[24] CAO M,LI H,SUN D,et al.Cancer screening in China:The current status,challenges,and suggestions[J].Cancer Lett,2021(506):120-127.
[25] 中国肺癌早诊早治专家组,中国西部肺癌研究协作中心.中国肺癌低剂量CT筛查指南(2023年版)[J].中国肺癌杂志,2023,26(1):1-9.
[26] 林丹丹,吴晓青,刘婷,等.2082例行肺部低剂量高分辨螺旋CT检查的健康体检者结果分析[J].中华肺部疾病杂志(电子版),2020,13(5):687-689.
[27] 毛宇,赵素清.无症状健康体检者胸部低剂量CT在早期肺癌筛查中的实用价值[J].中华胸部外科电子杂志,2019,6(4):212-218.
[28] LAM D C,LIAM C K,ANDARINI S,et al.Lung cancer screening in Asia:An expert consensus report[J].J Thorac Oncol,2023,18(10):1303-1322.
[29] 张倩倩. 低剂量螺旋CT对19923名健康体检者的肺部检查结果分析[J].影像研究与医学应用,2022,6(13):176-178.
[30] 牟云飞,王园.低剂量螺旋CT与胸部X线筛查肺癌高危人群的临床应用价值研究[J].中国CT和MRI杂志,2020,18(11):67-69.